M&A Deal Summary |
|
---|---|
Date | 2007-10-04 |
Target | FoxHollow Technologies |
Sector | Medical Products |
Buyer(s) | ev3 |
Deal Type | Add-on Acquisition |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 2000 |
Sector | Healthcare Services |
Employees | 1,350 |
ev3 is the endovascular technology company that brings together the right people, technology, and resources to successfully identify and provide meaningful clinical solutions to underserved markets in the endovascular field. ev3 has been dedicated to developing breakthrough and clinically proven technologies for the endovascular treatment of peripheral vascular and neurovascular diseases.
DEAL STATS | # |
---|---|
Overall | 2 of 2 |
Sector (Medical Products) | 2 of 2 |
Type (Add-on Acquisition) | 1 of 1 |
State (California) | 2 of 2 |
Country (United States) | 2 of 2 |
Year (2007) | 1 of 1 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2006-01-06 |
Micro Therapeutics
Irvine, California, United States Micro Therapeutics is a develops, manufactures and markets minimally invasive medical devices for the diagnosis and treatment of vascular disease. The company is focused on catheter-based, or endovascular, technologies for the minimally invasive treatment of neurovascular disorders of the brain associated with stroke. |
Buy | - |